Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

K+S AG KPLUY OTC

Other OTC • Basic Materials • Chemicals • DE • USD

SharesGrow Score
44/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$12.50
+41%

K+S AG (KPLUY) is a Chemicals company in the Basic Materials sector, currently trading at $8.87. It has a SharesGrow Score of 44/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Analyst consensus target is KPLUY = $13 (+41% upside).

Financials: revenue is $3.5B, -13.8%/yr average growth. Net income is $1.0B (loss), growing at -554.9%/yr. Net profit margin is -29.5% (negative). Gross margin is -31.1% (-74.4 pp trend).

Balance sheet: total debt is $765M against $4.9B equity (Debt-to-Equity (D/E) ratio 0.16, conservative). Current ratio is 3.43 (strong liquidity). Debt-to-assets is 9.6%. Total assets: $7.9B.

Analyst outlook: 0 / 3 analysts rate KPLUY as buy (0%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 90/100 (Pass), Growth 15/100 (Fail), Past 50/100 (Partial), Health 67/100 (Partial), Moat 24/100 (Fail), Future 52/100 (Partial), Income 10/100 (Fail).

$12.50
▲ 40.97% Upside
Average Price Target
The 12-month price target for K+S AG is $12.50.

KPLUY SharesGrow Score Overview

44/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 90/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 50/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 24/100
Gross margin is + market cap
FUTURE 52/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — KPLUY

✓
VALUE Pass
90/100
KPLUY trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $13, implying +46.6% from the current price $9. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✗
GROWTH Fail
15/100
KPLUY: -13.8%/yr revenue is, -554.9%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
50/100
KPLUY: 2 / 4 years profitable. weak. Score = 2 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
67/100
Balance sheet KPLUY: Debt-to-Equity (D/E) ratio 0.16 (conservative), Current ratio is 3.43 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
24/100
KPLUY: Gross margin is -31.1% (-74.4 pp trend), $3B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 24/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
52/100
Analyst outlook: 0 / 3 analysts rate KPLUY as buy (0%). Analyst consensus target is $13 (+46.6% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
KPLUY: Net profit margin is -29.5%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range6.24-10.67
Volume202
Avg Volume (30D)6.04K
Market Cap$3.18B
Beta (1Y)0.31
Dividend Yield$0.0800
Share Statistics
EPS (TTM)-2.88
Shares Outstanding$358.2M
IPO Date2010-04-26
Employees11,382
CEOChristian H. Meyer
Financial Highlights & Ratios
Revenue (TTM)$3.5B
Gross Profit$-1.09B
EBITDA$-937.86M
Net Income$-1.03B
Operating Income$-1.38B
Total Cash$480.3M
Total Debt$765.37M
Net Debt$331.76M
Total Assets$7.94B
Price / Earnings (P/E)-3.1
Price / Sales (P/S)0.91
Analyst Forecast
1Y Price Target$12.50
Target High$12.50
Target Low$12.50
Upside+41.0%
Rating ConsensusSell
Analysts Covering3
Buy 0% Hold 33% Sell 67%
Company Info
CountryDE
ExchangeOther OTC
CurrencyUSD
ISINUS48265W1080

Price Chart

Track all markets on TradingView
KPLUY
K+S AG ↗  ·  Other OTC
Basic Materials • Chemicals
6.24 52WK RANGE 10.67

People Also View

CTA-PB
CTA-PB
E. I. du Pont de Nemours and Company
$68.60
+0.88%
 CTVA
CTVA
Corteva, Inc.
$81.32
-1.97%
 CF
CF
CF Industries Holdings, Inc.
$120.81
+1.56%
 YRAIF
YRAIF
Yara International ASA
$58.00
+0.00%
 MOS
MOS
The Mosaic Company
$23.73
-0.88%
 ICL
ICL
ICL Group Ltd
$5.33
+0.19%
 FMC
FMC
FMC Corporation
$17.42
-0.06%
 BWEL
BWEL
JG Boswell Company
$594.80
+0.44%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message